• UAE-based healthtech Valeo Health has raised $12 million in its Series B funding round, bringing total funding to date to $20 million. 
• The round was led by Flintera, with participation from existing investors Nuwa Capital, FJ Labs, Oryx, and Mindshift Capital, as well as new investors like Oraseya and Eirad.
• Co-founded by Sundeep Sahni, Nadine Karadag, and Ankur Majumder in 2021, Valeo is a personalised, data-driven healthcare platform. 
• The investment will be used to accelerate the company’s mission to make personalised, science-backed healthcare solutions more accessible across the KSA, UAE and the rest of the GCC.

Press release:

Valeo Health, a pioneering leader in AI-driven healthcare, has successfully raised $12 million in its Series B funding round, bringing its total funding raised to $20 million to date. Co-founded by Sundeep Sahni, Nadine Karadag, and Ankur Majumder, Valeo Health is redefining personalised, data-driven healthcare across the region. The round was led by Flintera, with participation from existing investors Nuwa Capital, FJ Labs, Oryx, and Mindshift Capital, as well as new investors like Oraseya and Eirad.  The investment will be used to accelerate the company’s mission to make personalised, science-backed healthcare solutions more accessible across the KSA, UAE and the rest of the GCC.

This funding round reinforces the growing confidence in Valeo Health’s innovative approach to AI-powered healthcare at home. The latest investment follows the company’s rapid expansion and success in delivering at-home healthcare, personalised treatment plans tailored to individual needs and Valeo’s proprietary Longevity technology.

“We are thrilled by the strong investor support as we continue to redefine how people engage with their health,” said Sundeep Sahni, CEO & Co-Founder of Valeo Health. “This funding enables us to scale our AI technology, enhance our product offerings, and expand our reach, ensuring more individuals benefit from proactive healthcare solutions.” Co-founder Nadine Karadag added, “This investment validates our team’s hard work and strengthens our ability to scale personalised healthcare across the region.”

“Valeo is not just building another health-tech platform — it's shaping the future of preventive care in the region. At Flintera, we back founders who merge cutting-edge technology with clear, scalable vision, and Sundeep and his team embody exactly that. HealthTech is one of our key investment priorities, and we’re excited that our first investment in the region is with such a strong, mission-driven company. We’re also deeply committed to bringing the best technologies to the region and look forward to supporting more exceptional entrepreneurs and sustainable business models across the GCC.”

“We first backed Valeo in 2021, drawn by the strength of the founding team and a clear opportunity to address a real market need. Since then, Sundeep, Nadine and Ankur have delivered with focus and consistency, building an integrated platform with strong cross-border potential and impressive year-over-year growth. A key to their success has been providing customers with real benefits across multiple touchpoints and associated journeys.  With this round, we have the opportunity to deepen the customer centricity and provide even more value to our most important stakeholder.  We’re excited to continue supporting Valeo as they scale and take the business to the next stage.” - Nitin Reen, Partner at Nuwa Capital

As a trusted name in the KSA and UAE’s health-tech space, Valeo Health is committed to empowering individuals with real-time insights and tailored health and wellness solutions. The funding positions the company to expand its footprint regionally, further revolutionising the future of personalised healthcare.